Biden administration’s limit on drug industry middlemen backfires, pharmacists say

The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say.

Exploring the link between rheumatoid arthritis and atrial fibrillation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Observational research has indicated that individuals diagnosed with rheumatoid arthritis (RA) have an elevated

February 24, 2024

Fact-Checking False or Misleading Claims Made During the Democratic Convention

The Democrats’ star-studded, 4-day convention drew to a close as Vice President Kamala Harris accepted the party’s nomination for president. The festivities were high on

August 24, 2024

FTC Sues Top Pharmacy Benefit Managers Over Insulin Prices

The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say has made the price of

September 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.